EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Manufacturing process development strategies for high concentration biologic drug products: from downstream processing to fill-finish

Rama Prajapati, Mittal Darji, Seyyed Majid Eslami, Sheyda Ranjbar, Md Jobair Hossen Jony, Zixuan Zhen, Ray Yu Wang, Xiaolin Charlie Tang, Xiuling Lu

Advanced Drug Delivery Reviews · 2026-07 · 234 · 115877

DOI: 10.1016/j.addr.2026.115877 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-07. Verfasst von Rama Prajapati und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA. Hauptthemen laut MEDLINE: Biological Products, Proteins, Technology, Pharmaceutical. Die Arbeit nennt 162 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a growing demand for high-concentration protein formulations (HCPFs), driven by certain therapeutics that require high doses and the volume limitations of subcutaneous administration. However, downstream processing and fill-finish for these HCPFs plays a critical role and remains a major limitation. It accounts for nearly 60% of the total production cost and faces significant challenges in scalability and efficiency. These challenges are largely attributed to inherent complexity, which involve multiple unit operations such as ultrafiltration, bulk drug substance freezing, thawing, mixing, sterile filtration and drug product fill-finish. This review provides a comprehensive overview of downstream processing and fill-finish for high-concentration protein formulations, highlighting the key challenges, particularly related to drug stability, (such as protein aggregation, or particulate formation), viscosity and solubility (such as turbidity or phase separation). Addressing these multifactorial challenges demands various strategies that include formulation and process optimization, and the use of specialized delivery systems which are discussed herewith. Moreover, emerging trends such as process analytical technologies (PAT), use of non-aqueous delivery vehicles and potential of using solid suspensions are also highlighted as promising strategies for overcoming the current limitations. Finally, to address the real-world applications, case studies of two FDA-approved high-concentration formulations (up to 200 mg/mL) are presented illustrating the need for formulation and process design for enabling successful clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsProteinsTechnology, PharmaceuticalHumansDrug StabilityChemistry, PharmaceuticalSolubilityAnimals

Stichwörter der Autor:innen

AggregationDownstream processingFill-FinishHigh-concentration protein formulations (HCPF)StabilityViscosity

Substanzen

Biological ProductsProteins

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.
  • Injectable Drug Product Development, Alexion, AstraZeneca Rare Disease, New Haven, CT 06510, USA.
  • Formulation Development, Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA. Electronic address: xiuling.lu@uconn.edu.

Zitieren

APA

Prajapati, R., Darji, M., Eslami, S. M., Ranjbar, S., Jony, M. J. H., Zhen, Z., Wang, R. Y., Tang, X. C., & Lu, X. (2026). Manufacturing process development strategies for high concentration biologic drug products: from downstream processing to fill-finish. Advanced Drug Delivery Reviews, 234, 115877. https://doi.org/10.1016/j.addr.2026.115877

Vancouver

Prajapati R, Darji M, Eslami SM, Ranjbar S, Jony MJH, Zhen Z, et al. Manufacturing process development strategies for high concentration biologic drug products: from downstream processing to fill-finish. Advanced Drug Delivery Reviews. 2026;234:115877. doi:10.1016/j.addr.2026.115877

BibTeX
@article{Prajapati2026,
  author = {Prajapati, Rama and Darji, Mittal and Eslami, Seyyed Majid and Ranjbar, Sheyda and Jony, Md Jobair Hossen and Zhen, Zixuan and Wang, Ray Yu and Tang, Xiaolin Charlie and Lu, Xiuling},
  title = {Manufacturing process development strategies for high concentration biologic drug products: from downstream processing to fill-finish},
  journal = {Advanced Drug Delivery Reviews},
  year = {2026},
  volume = {234},
  pages = {115877},
  doi = {10.1016/j.addr.2026.115877}
}
Kostenlos starten →